nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0636	0.0636	CbGpPWpGaD
Indacaterol—ADRB2—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0622	0.0622	CbGpPWpGaD
Indacaterol—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0334	0.0334	CbGpPWpGaD
Indacaterol—ADRB2—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0327	0.0327	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0225	0.0225	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.022	0.022	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.022	0.022	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0215	0.0215	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0189	0.0189	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0185	0.0185	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0185	0.0185	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0181	0.0181	CbGpPWpGaD
Indacaterol—UGT1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0173	0.0173	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0133	0.0133	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0131	0.0131	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0128	0.0128	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0126	0.0126	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0124	0.0124	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0121	0.0121	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.012	0.012	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0118	0.0118	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0118	0.0118	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0117	0.0117	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0116	0.0116	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0114	0.0114	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0112	0.0112	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.011	0.011	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0109	0.0109	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0106	0.0106	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0104	0.0104	CbGpPWpGaD
Indacaterol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0104	0.0104	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0102	0.0102	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0101	0.0101	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00993	0.00993	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00988	0.00988	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0098	0.0098	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00971	0.00971	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00959	0.00959	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00913	0.00913	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00893	0.00893	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00764	0.00764	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00761	0.00761	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00747	0.00747	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00744	0.00744	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0064	0.0064	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00626	0.00626	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00522	0.00522	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00507	0.00507	CbGpPWpGaD
Indacaterol—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00489	0.00489	CbGpPWpGaD
Indacaterol—UGT1A1—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00486	0.00486	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00434	0.00434	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0043	0.0043	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00428	0.00428	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00425	0.00425	CbGpPWpGaD
Indacaterol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00425	0.00425	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00424	0.00424	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00422	0.00422	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00421	0.00421	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00416	0.00416	CbGpPWpGaD
Indacaterol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00416	0.00416	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00413	0.00413	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00381	0.00381	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00372	0.00372	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00356	0.00356	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.0035	0.0035	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00331	0.00331	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00295	0.00295	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00288	0.00288	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00284	0.00284	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00283	0.00283	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00282	0.00282	CbGpPWpGaD
Indacaterol—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0028	0.0028	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00277	0.00277	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00277	0.00277	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00271	0.00271	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00257	0.00257	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00252	0.00252	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00252	0.00252	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00247	0.00247	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00239	0.00239	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00238	0.00238	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00234	0.00234	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00233	0.00233	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00232	0.00232	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00228	0.00228	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00227	0.00227	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00225	0.00225	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00223	0.00223	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00221	0.00221	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0022	0.0022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00217	0.00217	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00216	0.00216	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00212	0.00212	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0021	0.0021	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00205	0.00205	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00205	0.00205	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00201	0.00201	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00195	0.00195	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00194	0.00194	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00193	0.00193	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00192	0.00192	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00191	0.00191	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00189	0.00189	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0018	0.0018	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00176	0.00176	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00168	0.00168	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00164	0.00164	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0016	0.0016	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00157	0.00157	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00156	0.00156	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00156	0.00156	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00154	0.00154	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00153	0.00153	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00153	0.00153	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00151	0.00151	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00149	0.00149	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00148	0.00148	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00147	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00147	0.00147	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00145	0.00145	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00145	0.00145	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00144	0.00144	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00144	0.00144	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00142	0.00142	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00142	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00137	0.00137	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00134	0.00134	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00128	0.00128	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00125	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00123	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00116	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00115	0.00115	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00109	0.00109	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00106	0.00106	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000999	0.000999	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000986	0.000986	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000977	0.000977	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000965	0.000965	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000958	0.000958	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000949	0.000949	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000937	0.000937	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000929	0.000929	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000883	0.000883	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000863	0.000863	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000862	0.000862	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000858	0.000858	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000855	0.000855	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000843	0.000843	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000841	0.000841	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00084	0.00084	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000839	0.000839	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000836	0.000836	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00083	0.00083	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000824	0.000824	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000822	0.000822	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000822	0.000822	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000812	0.000812	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000806	0.000806	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000804	0.000804	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000803	0.000803	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000803	0.000803	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000801	0.000801	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000798	0.000798	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000793	0.000793	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00079	0.00079	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000784	0.000784	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000776	0.000776	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000773	0.000773	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000763	0.000763	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000759	0.000759	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000756	0.000756	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000753	0.000753	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000746	0.000746	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000737	0.000737	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000734	0.000734	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000702	0.000702	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000687	0.000687	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000642	0.000642	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000611	0.000611	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000583	0.000583	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00057	0.00057	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00056	0.00056	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000541	0.000541	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000533	0.000533	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00053	0.00053	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000514	0.000514	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000509	0.000509	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000498	0.000498	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000492	0.000492	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000486	0.000486	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000483	0.000483	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000481	0.000481	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000473	0.000473	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000463	0.000463	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000459	0.000459	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000451	0.000451	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000449	0.000449	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000445	0.000445	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000441	0.000441	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000435	0.000435	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000415	0.000415	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000406	0.000406	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000368	0.000368	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000368	0.000368	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000362	0.000362	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000337	0.000337	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000329	0.000329	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000294	0.000294	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00029	0.00029	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000284	0.000284	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00028	0.00028	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000227	0.000227	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000227	0.000227	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000223	0.000223	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000223	0.000223	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000221	0.000221	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000209	0.000209	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000207	0.000207	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000181	0.000181	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.000173	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000154	0.000154	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000151	0.000151	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000137	0.000137	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000136	0.000136	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	9.57e-05	9.57e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	5.89e-05	5.89e-05	CbGpPWpGaD
